Summary
A DRUG proved to shrink breast cancer tumours before women undergo surgery has been rejected for use on the NHS in Scotland.
Last year, a small study in the US showed that lapatinib (Tyverb) shrank tumours by an average of more than 60 per cent before women had surgery.See the full content of this document
Extract
Breast Cancer Drug Rejected for Scotland
The Scottish Medicines Consor...
See the full content of this document
Sponsored links
ver las páginas en versión mobile | web
ver las páginas en versión mobile | web
© Copyright 2012, vLex. All Rights Reserved.
Contents in vLex United Kingdom
Explore vLex
For Professionals
For Partners
Company
Other documents:
Golden Girl Natalie Wins Eight Medals | Mark Puts a Face to His Illness ; a Goole Man with a Genetic Condition Which He Claims Was Misdiagnosed by Doctors ha... | Just Men Allowed in Beer-Only Pub | University Climbs List | Webco Industries, Inc. Reports Fiscal 2009 First Quarter Results. | Fifth-Graders, Teachers Slug It Out | Shooting in North Long Beach Park Leaves One Man Wounded | Research and Markets Printed Organic & Flexible Electronics Forecasts Players & Opportunities 2009-2029 Report Shows Activities of over 700 Leading Companies.
